Swaranjali Pawar

Swaranjali Pawar

Auto-generated profile, based on publicly available information

Swaranjali Pawar

Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
SRSanket Rathod
Sanket Rathod
PCPooja Chavan
Pooja Chavan
DMDeepak Mahuli
Deepak Mahuli
SRSneha Rochlani
Sneha Rochlani
SSShalini Shinde
Shalini Shinde
FTFiroj A. Tamboli
Firoj A. Tamboli

20 June 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SRSanket Rathod
Sanket Rathod
SDSreenath Dey
Sreenath Dey
SPSwaranjali Pawar
Swaranjali Pawar
RDRakesh Dhavale
Rakesh Dhavale
PCPrafulla Choudhari
Prafulla Choudhari
HMHarinath More
Harinath More
The cases of bacterial multidrug resistance are increasing every year and becoming a serious concern for human health. Multidrug efflux pumps are key players in the formation of antibiotic resistance, which transfer out a broad spectrum of drugs from the cell and convey resistance to the host. Efflux pumps have significantly reduced the efficacy of the previously available antibiotic armory, thereby increasing the frequency of therapeutic failures. In gram-negative bacteria, the AcrAB-TolC efflux pump is the principal transporter of the substrate and plays a major role in the formation of antibiotic resistance. In the current work, advanced computer-aided drug discovery approaches were utilized to find hit molecules from the library of biogenic chalcones against the bacterial AcrB efflux pump. The results of the performed computational studies via molecular docking, drug-likeness prediction, pharmacokinetic profiling, pharmacophore mapping, density functional theory, and molecular dynamics simulation study provided ZINC000004695648, ZINC000014762506, ZINC000014762510, ZINC000095099506, and ZINC000085510993 as stable hit molecules against the AcrB efflux pumps. Identified hits could successfully act against AcrB efflux pumps after optimization as lead molecules.Communicated by Ramaswamy H. Sarma.
1